Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Drops By 20.0%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZNGet Free Report) was the target of a large decrease in short interest in February. As of February 15th, there was short interest totalling 1,600 shares, a decrease of 20.0% from the January 31st total of 2,000 shares. Based on an average trading volume of 15,900 shares, the short-interest ratio is presently 0.1 days.

Enzon Pharmaceuticals Price Performance

ENZN traded down $0.01 during trading on Monday, reaching $0.07. 2,425 shares of the company were exchanged, compared to its average volume of 12,784. The firm has a 50 day moving average of $0.09 and a 200 day moving average of $0.12. Enzon Pharmaceuticals has a 52 week low of $0.06 and a 52 week high of $0.27.

About Enzon Pharmaceuticals

(Get Free Report)

Enzon Pharmaceuticals, Inc, together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Recommended Stories

Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.